Keywords: Vertex, Kalydeco, Cystic fibrosis, EU and US regulatory filings, Chief executive

Vertex updates on US and EU Kalydeco filings; to get new CEO

Article | 16 December 2011

Print This

US drugmaker Vertex Pharmaceuticals (Nasdaq: VRTX) says that the US Food and Drug Administration has accepted the New Drug Application ...

Enjoying this article? To continue reading you need to login or subscribe.

Subscribe now
for unlimited access to all articles

Subscriptions are £60 per month, pay as you go.
Find out more details.

Already a subscriber? Click here to log in